Advertisement
Screener

RAFAEL HOLDINGS, INC. (RFL) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

Rafael Holdings, Inc. Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • Rafael Holdings, Inc. return tang equity for the quarter ending 2026-04-30 was -54.28%, a change of -12.82% year-over-year.
  • Rafael Holdings, Inc. return tang equity for the quarter ending 2026-01-31 was -53.06%, a change of 21.45% year-over-year.
  • Rafael Holdings, Inc. return tang equity for the quarter ending 2025-10-31 was -45.89%, a change of 8.97% year-over-year.
  • Rafael Holdings, Inc. return tang equity for the quarter ending 2025-07-31 was -39.41%, a change of 2.88% year-over-year.
  • Rafael Holdings, Inc. return tang equity for fiscal 2025 was -39.41%, a change of 2.88% from fiscal 2024.
  • Rafael Holdings, Inc. return tang equity for fiscal 2024 was -42.29%, a change of -40.35% from fiscal 2023.
  • Rafael Holdings, Inc. return tang equity for fiscal 2023 was -1.95%, a change of 126.72% from fiscal 2022.
  • Rafael Holdings, Inc. return tang equity for fiscal 2022 was -128.67%, a change of -111.76% from fiscal 2021.
Available history
2016-07-31 to 2026-04-30
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-04-30-54.28%-$32.55M$59.97M
2026-01-31-53.06%-$33.11M$62.39M
2025-10-31-45.89%-$31.33M$68.28M
2025-07-31-39.41%-$30.52M$77.44M
2025-04-30-41.46%-$22.89M$55.21M
2025-01-31-74.51%-$50.47M$67.73M
2024-10-31-54.85%-$39.78M$72.52M
2024-07-31-42.29%-$34.41M$81.36M
2024-04-30-33.74%-$28.72M$85.14M
2024-01-312.26%$2.19M$96.8M
2023-10-31-7.55%-$7.11M$94.11M
2023-07-31-1.95%-$1.88M$96.22M
2023-04-3010.34%$9.77M$94.49M
2023-01-315.89%$5.66M$96.13M
2022-10-316.88%$6.85M$99.56M
2022-07-31-127.69%-$123.61M$96.8M
2022-04-30-155.79%-$147.22M$94.5M
2022-01-31-145.41%-$144.32M$99.25M
2021-10-31-133.59%-$150.5M$112.66M
2021-07-31-16.92%-$23.06M$136.3M
2021-04-30-12.82%-$18.06M$140.85M
2021-01-31-13.02%-$17.57M$134.98M
2020-10-31-8.21%-$10.59M$128.91M
2020-07-31-8.26%-$10.75M$130.12M
2020-04-30-5.31%-$7.2M$135.42M
2020-01-31-4.39%-$6.04M$137.51M
2019-10-31-4.19%-$5.81M$138.56M
2019-07-31-3.77%-$4.69M$124.36M
2019-04-30-2.95%-$3.75M$127.02M
2019-01-31-2.56%-$3.28M$128.07M
2018-10-31-2.43%-$2.8M$115.36M
2018-07-31-10.06%-$11.65M$115.8M
2018-04-30-9.14%-$10.49M$114.77M
2018-01-31-19.11%-$10.03M$52.47M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-07-31-39.41%-$30.52M$77.44M
2024-07-31-42.29%-$34.41M$81.36M
2023-07-31-1.95%-$1.88M$96.31M
2022-07-31-128.67%-$124.66M$96.88M
2021-07-31-16.91%-$23.06M$136.38M
2020-07-31-8.26%-$10.75M$130.2M
2019-07-31-3.77%-$4.69M$124.44M
2018-07-31-10.06%-$11.65M$115.8M
2017-07-310.22%$138,000.00$62.08M
2016-07-311.45%$710,000.00$48.81M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aditxt, Inc. (ADTX)United States$0.000B
CDT Equity Inc. (CDT)United States$0.000B-0.01
Protagenic Therapeutics, Inc.\new (PTIX)United States$0.001B
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
Nexentis Technologies Inc. (NXTS)$0.002B
ORAGENICS INC (OGEN)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B